Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (251-260 of 292) with videos related to

Pageof 30
Sort By:
Annals of Surgical Oncology|July 19, 2012
Risk of cancer-specific mortality following recurrence after radical nephroureterectomyMichael Rink, Daniel Sjoberg, Evi Comploj, et al.
The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.
BJUI Compass|November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladderKira Furlano, Henning Plage, Sebastian Hofbauer, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
World Journal of Urology|February 10, 2015
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladderVladimir Novotny, Michael Froehner, Matthias May, et al.
World Journal of Urology|September 27, 2012
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinomaHarun Fajkovic, Eugene K Cha, Evanguelos Xylinas, et al.
World Journal of Urology|July 27, 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, et al.
BMC Urology|April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Urologia Internationalis|July 4, 2015
Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter StudyThomas Martini, Atiqullah Aziz, Florian Roghmann, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Pageof 30

Showing results (251-260 of 292) with videos related to

Sort By:
Pageof 30
Annals of Surgical Oncology|July 19, 2012
Risk of cancer-specific mortality following recurrence after radical nephroureterectomyMichael Rink, Daniel Sjoberg, Evi Comploj, et al.
The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.
BJUI Compass|November 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladderKira Furlano, Henning Plage, Sebastian Hofbauer, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
World Journal of Urology|February 10, 2015
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladderVladimir Novotny, Michael Froehner, Matthias May, et al.
World Journal of Urology|September 27, 2012
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinomaHarun Fajkovic, Eugene K Cha, Evanguelos Xylinas, et al.
World Journal of Urology|July 27, 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, et al.
BMC Urology|April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Urologia Internationalis|July 4, 2015
Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter StudyThomas Martini, Atiqullah Aziz, Florian Roghmann, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Pageof 30